Maternal vitamin C regulates reprogramming of DNA methylation and germline development.

PMID:  Nature. 2019 Sep ;573(7773):271-275. Epub 2019 Sep 4. PMID: 31485074 Abstract Title:  Maternal vitamin C regulates reprogramming of DNA methylation and germline development. Abstract:  Development is often assumed to be hardwired in the genome, but several lines of evidence indicate that it is susceptible to environmental modulation with potential long-term consequences, including in mammals. …

Cucurbitacin B exerts antiaging effects in yeast by regulating autophagy and oxidative stress.

PMID:  Oxid Med Cell Longev. 2019 ;2019:4517091. Epub 2019 Jun 2. PMID: 31281576 Abstract Title:  Cucurbitacin B Exerts Antiaging Effects in Yeast by Regulating Autophagy and Oxidative Stress. Abstract:  The budding yeasthas been used as a model organism for the basic mechanism of aging, which provides useful assay systems for measuring both replicative and chronological …

Ascorbic acid mitigates the deleterious effects of nicotine on tendon stem cells.

PMID:  Connect Tissue Res. 2019 Sep 5:1-11. Epub 2019 Sep 5. PMID: 31488012 Abstract Title:  Ascorbic acid mitigates the deleterious effects of nicotine on tendon stem cells. Abstract:  : Nicotine causes tendon degeneration, whereas ascorbic acid imparts beneficial effects on tendon cells. Tendon stem cells (TSCs) play a vital role in maintaining tissue integrity and …

High dose vitamin c may inhibit proliferation of breast cancer cells both in vitro and in vivo through reducing glycolysis and protein synthesis.

PMID:  Zhejiang Da Xue Xue Bao Yi Xue Ban. 2019 May 25 ;48(3):296-302. PMID: 31496162 Abstract Title:  [High dose vitamin C inhibits proliferation of breast cancer cells through reducing glycolysis and protein synthesis]. Abstract:  OBJECTIVE: To investigate the effects of high dose vitamin C (VC) on proliferation of breast cancer cells and to explore its …

Vitamin C in combination with inhibition of mutant IDH1 synergistically activates TET enzymes and epigenetically modulates gene silencing in colon cancer.

PMID:  Epigenetics. 2019 Sep 11. Epub 2019 Sep 11. PMID: 31505989 Abstract Title:  Vitamin C in combination with inhibition of mutant IDH1 synergistically activates TET enzymes and epigenetically modulates gene silencing in colon cancer cells. Abstract:  Mutations in the enzyme isocitrate dehydrogenase 1 (IDH1) lead to metabolic alterations and a sustained formation of 2-hydroxyglutarate (2-HG). …

Late gadolinium enhancement in cardiac amyloidosis: attributable both to interstitial amyloid deposition and subendocardial fibrosis caused by ischemia.

PMID:  Heart Vessels. 2016 Jun ;31(6):990-5. Epub 2015 Mar 21. PMID: 25794983 Abstract Title:  Late gadolinium enhancement in cardiac amyloidosis: attributable both to interstitial amyloid deposition and subendocardial fibrosis caused by ischemia. Abstract:  Gadolinium contrast agents used for late gadolinium enhancement (LGE) distribute in the extracellular space. Global diffuse myocardial LGE pronounced in the subendocardial …

Gadolinium deposition disease: Initial description of a disease that has been around for a while.

PMID:  Magn Reson Imaging. 2016 Dec ;34(10):1383-1390. Epub 2016 Aug 13. PMID: 27530966 Abstract Title:  Gadolinium deposition disease: Initial description of a disease that has been around for a while. Abstract:  PURPOSE: To describe the clinical manifestations of presumed gadolinium toxicity in patients with normal renal function.MATERIALS AND METHODS: Participants were recruited from two online …

Gadolinium tissue deposition in the periodontal ligament of mice with reduced renal function.

PMID:  Toxicol Lett. 2019 Feb ;301:157-167. Epub 2018 Nov 23. PMID: 30476537 Abstract Title:  Gadolinium tissue deposition in the periodontal ligament of mice with reduced renal function exposed to Gd-based contrast agents. Abstract:  Gadolinium deposition in tissue is linked to nephrogenic systemic fibrosis (NSF): a rare disorder occurring in patients with severe chronic kidney disease …

A structured survey on adverse events occurring within 24 hours after intravenous exposure to gadodiamide or gadoterate meglumine.

PMID:  Invest Radiol. 2019 04 ;54(4):191-197. PMID: 30379729 Abstract Title:  A Structured Survey on Adverse Events Occurring Within 24 Hours After Intravenous Exposure to Gadodiamide or Gadoterate Meglumine: A Controlled Prospective Comparison Study. Abstract:  OBJECTIVE: This study compares the incidence of new-onset symptoms within 24 hours after enhanced magnetic resonance imaging (eMRI) with intravenous administration …

Cumulative gadodiamide administration leads to brain gadolinium deposition in early multiple sclerosis.

PMID:  Neurology. 2019 Aug 6 ;93(6):e611-e623. Epub 2019 Jul 8. PMID: 31285398 Abstract Title:  Cumulative gadodiamide administration leads to brain gadolinium deposition in early MS. Abstract:  OBJECTIVE: Frequent administration of gadolinium-based contrast agents in multiple sclerosis (MS) may increase signal intensity (SI) unenhanced T1-weighted imaging MRI throughout the brain. We evaluated the association between lifetime …

Design a site like this with WordPress.com
Get started